CDMO News Days Hours Minutes Seconds Download Full Agenda CDMO News SK pharmteco Announces $200M+ U.S. Investment in Small Molecules and Peptides SK pharmteco Announces $200M+ U.S. Investment in Small Molecules and Peptides 53Biologics Announces €2M+ Investment in New Lyophilization Capacity TAPI Appoints Serge Rogasik as Chief Executive Officer ALK Expands Catalent Partnership to Secure Long-Term Allergy Tablet Supply OnDosis and Adare Pharma Solutions Launch U.S. ADHD Drug-Device Collaboration Ensera Launches Alliance Network for Drug-Device Combination Products Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center NorthStar Medical Technologies Secures Up to $185M Growth Capital Facility Piramal Pharma Solutions Receives $1.75M Ontario Investment for Aurora Site Minaris Adds Viral Vectors Business Unit to Expand CGT Model Genezen Partners on AAV9 Gene Therapy for Ultra-Rare ARCA2 Disorder More CDMO News 53Biologics Announces €2M+ Investment in New Lyophilization Capacity TAPI Appoints Serge Rogasik as Chief Executive Officer ALK Expands Catalent Partnership to Secure Long-Term Allergy Tablet Supply OnDosis and Adare Pharma Solutions Launch U.S. ADHD Drug-Device Collaboration Ensera Launches Alliance Network for Drug-Device Combination Products Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center NorthStar Medical Technologies Secures Up to $185M Growth Capital Facility Piramal Pharma Solutions Receives $1.75M Ontario Investment for Aurora Site Minaris Adds Viral Vectors Business Unit to Expand CGT Model Genezen Partners on AAV9 Gene Therapy for Ultra-Rare ARCA2 Disorder More CDMO News White Paper[Download] Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report
